Glassy cell carcinoma of the cervix uteri

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:213833C53.0C53.1C53.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Glassy cell carcinoma of the cervix uteri is an extremely rare and aggressive subtype of cervical cancer, classified as a poorly differentiated variant of adenosquamous carcinoma. It is named for the distinctive ground-glass appearance of the tumor cells' cytoplasm when viewed under the microscope. This neoplasm arises in the cervix and primarily affects the female reproductive system. It can present with symptoms common to other cervical cancers, including abnormal vaginal bleeding (such as postcoital bleeding or intermenstrual bleeding), pelvic pain, and vaginal discharge. As the disease progresses, it may spread to surrounding pelvic structures, lymph nodes, and distant organs. Glassy cell carcinoma accounts for a very small percentage of all cervical carcinomas, estimated at approximately 1–2% of cases. It tends to occur in relatively younger women compared to other cervical cancer subtypes and is notable for its aggressive clinical behavior, with a poorer prognosis than typical squamous cell carcinoma or adenocarcinoma of the cervix. The tumor is often poorly responsive to conventional radiation therapy alone, which distinguishes it from more common cervical cancer types. Treatment typically involves a multimodal approach. Radical hysterectomy with pelvic lymph node dissection is often recommended for early-stage disease. Given the tumor's relative resistance to radiation, combined chemoradiation therapy is frequently employed, particularly for advanced-stage disease. Chemotherapy regimens similar to those used for other aggressive cervical cancers may be utilized. Due to the rarity of this tumor, there are no standardized treatment protocols specific to glassy cell carcinoma, and management decisions are often guided by case reports, small case series, and extrapolation from treatment strategies for other high-grade cervical cancers. Early detection and prompt treatment are critical for improving outcomes.

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Glassy cell carcinoma of the cervix uteri.

View clinical trials →

No actively recruiting trials found for Glassy cell carcinoma of the cervix uteri at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Glassy cell carcinoma of the cervix uteri community →

No specialists are currently listed for Glassy cell carcinoma of the cervix uteri.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Glassy cell carcinoma of the cervix uteri.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Glassy cell carcinoma of the cervix uteriForum →

No community posts yet. Be the first to share your experience with Glassy cell carcinoma of the cervix uteri.

Start the conversation →

Latest news about Glassy cell carcinoma of the cervix uteri

No recent news articles for Glassy cell carcinoma of the cervix uteri.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Glassy cell carcinoma of the cervix uteri

What is Glassy cell carcinoma of the cervix uteri?

Glassy cell carcinoma of the cervix uteri is an extremely rare and aggressive subtype of cervical cancer, classified as a poorly differentiated variant of adenosquamous carcinoma. It is named for the distinctive ground-glass appearance of the tumor cells' cytoplasm when viewed under the microscope. This neoplasm arises in the cervix and primarily affects the female reproductive system. It can present with symptoms common to other cervical cancers, including abnormal vaginal bleeding (such as postcoital bleeding or intermenstrual bleeding), pelvic pain, and vaginal discharge. As the disease pro

How is Glassy cell carcinoma of the cervix uteri inherited?

Glassy cell carcinoma of the cervix uteri follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Glassy cell carcinoma of the cervix uteri typically begin?

Typical onset of Glassy cell carcinoma of the cervix uteri is adult. Age of onset can vary across affected individuals.